top of page
Levron.png

LEVRON
Breaking The Vicious Cycle

LOG IN

We are developing a novel minimally invasive therapeutic device that provides adaptive treatment for NYHA stage 3 Heart Failure eliminating lung congestion.

About

Preventing cardiac decompensation, using a closed loop device that shifts fluids from the lung, reduces dyspnea and the cardiac workload

Our vision

Our Team

Amir Ronen is an entrepreneur and  a seasoned executive in the Israeli hi-tech scene. A co-founder and CEO for 15 years in the Heart Failure medical device space, and previously a VP in NASDAQ traded companies all which have been merged and acquired (Sensible Medical $150M; M-Systems $1.4B; Saifun $384M). Amir holds a BsC in Electronic Engineering from the Technion and an MBA from Kellogg IMBA.

Professor and former dean of the biomedical engineering faculty at the Technion and former president of the International Society for Heart Research Israel group. Prof. Landesberg holds a Phd. In biomedical engineering and an M.D. Cum-Laude both from the Technion

Dr. Eckhouse is the founder and chairman of Alon MedTech ventures, a major player in the Israeli medical eco system, founded and invested in 20+ companies. such as Syneron Medical (acquired for $400M) and Ventor technologies (acquired for $325M)

Prof. Offer Amir, MD, FACC, FESC

Professor of Cardiology, Faculty of Medicine, Hebrew University, Jerusalem.

Director Heart Institute, Hadassah Medical ,Center, Jerusalem, Israel

President, Israel Heart Society 

Board Member, Heart Failure Association of the European Society of Cardiology

GET IN TOUCH

Tavor 2 Building, 3rd Floor, Hakidma 28,  Yokneam, Israel

+972-54-3113699

Thanks for submitting!

bottom of page